Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99per week for the first 24weeks
Just $1.99per week for the first 24weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

Part of cannabis and small business and retail

Citron Research’s Andrew Left, one of the most prominent short-sellers on Wall Street, is bearish on Canadian cannabis producers such as Tilray Inc, despite big gains last week, as he expects them to be overtaken by U.S. rivals once recreational marijuana is legalized in the United States, he told the Reuters Global Investment Outlook Summit in New York on Monday.

“When U.S. LPs (companies) go public in the next few years it will make these Canadian companies laughable,” he said. “The cannabis trade is a perfect trade because the cannabis trade is a nonbranded, no-moat megatrend.”

Left, who said that he is launching a new hedge fund that will in part focus on the cannabis industry, said that he has been short Tilray since the company traded at $70. The stock was near $108 in midday trading on Monday.

Story continues below advertisement

Tilray’s shares more than doubled in September in the run-up to Canada’s legalization of marijuana on Oct. 17. Investors buying the stock have been hoping the company will get a share of the potentially massive American market if marijuana is federally legalized.

Recreational marijuana is currently legal in 10 states and many now see federal U.S. legalization as inevitable within the next five years.

Shares of Tilray jumped nearly 31 per cent on Friday after U.S. Attorney General Jeff Sessions resigned. Sessions, an opponent of marijuana’s legalization, had given prosecutors a green light to aggressively enforce federal laws against the drug in states where it has been decriminalized.

Should marijuana become federally legal, U.S. producers and brands will be the most likely to thrive in the domestic market, Left said. California, where recreational marijuana became legal under state law in January, will constitute a cannabis market at least five times as large as Canada itself, Left said.

“There will be winners. I understand why people are excited about it,” he said, noting that Canopy Growth Corp became “the global leader financially” in the industry after Corona beer maker Constellation Brands Inc invested more than $4-billion in the company. Left said he has no position in Canopy.

Left said that Tilray’s stock is also benefiting from the relatively small number of shares available until its lock-up expiration ends on Jan. 15, 2019, which is 180 days after the company went public in July.

“What happens the day the lock-up expires and the float doubles? What happens to the stock then?” Left asked.

Story continues below advertisement

Available now: Cannabis Professional, the authoritative e-mail newsletter tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now.

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

If you do not see your comment posted immediately, it is being reviewed by the moderation team and may appear shortly, generally within an hour.

We aim to have all comments reviewed in a timely manner.

Comments that violate our community guidelines will not be posted.

UPDATED: Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies